Нарушения физического развития у детей с хронической болезнью почек: роль иммунной дисфункции и хронического воспаления
Получена: 2026-05-28
Опубликована: 2026-11-18
Аннотация
Хроническая болезнь почек (ХБП) у детей развивается в период активного роста и сопро¬вождается нарушениями иммунитета. Обобщены данные 30 источников (1997–2026 гг.) о механизмах, оценке и коррекции нарушений физического развития при ХБП. Низкорослость выявляется примерно у 30% детей, получающих диализ. Выраженная низкорослость (рост ниже 1-го перцентиля на момент начала диализа) ассоциирована с приблизительно двукратным повышением риска смерти. Ведущие механизмы — белково-энергетическая недостаточность, ацидоз, минерально-костные нарушения, анемия и резистентность к гормону роста. У детей на диализе снижено число Т-лимфоцитов, уровни интерлейкина-6 и С-реактивного белка обратно связаны с ростом. В одном исследовании частота серопротекции после вакцинации против гепатита B составляла 100% у детей на додиализной стадии, 94% у пациентов на диализе и 64% у реципиентов почечного трансплантата. Коррекция включает нутритивную поддерж¬ку, лечение метаболических нарушений, профилактику инфекций и раннюю вакцинацию, терапию гормоном роста и трансплантацию с минимизацией глюкокортикоидов. Ограни-ченность данных по Узбекистану обосновывает необходимость собственных исследований физического развития и иммунного статуса.
Ключевые слова
Список литературы
-
Harambat J, van Stralen KJ, Kim JJ, Tizard EJ. Epidemiology of chronic kidney disease in children. Pediatr Nephrol. 2012;27(3):363–73. https://doi.org/10.1007/s00467-011-1939-1
-
Haffner D. Strategies for Optimizing Growth in Children With Chronic Kidney Disease. Front Pediatr. 2020;8:399. https://doi.org/10.3389/fped.2020.00399
-
Kato S, Chmielewski M, Honda H, Pecoits-Filho R, Matsuo S, Yuzawa Y, et al. Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol. 2008;3(5):1526–33. https://doi.org/10.221 5/CJN.00950208
-
De Benedetti F, Alonzi T, Moretta A, Lazzaro D, Costa P, Poli V, et al. Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation. J Clin Invest. 1997;99(4):643–50. https://doi.org/10.1172/JCI119207
-
Furth SL, Stablein D, Fine RN, Powe NR, Fivush BA. Adverse clinical outcomes associated with short stature at dialysis initiation: a report of the North American Pediatric Renal Transplant Cooperative Study. Pediatrics. 2002;109(5):909–13. https://doi.org/10.1542/peds.109.5.909
-
Rodig NM, McDermott KC, Schneider MF, Hotchkiss HM, Yadin O, Seikaly MG, et al. Growth in children with chronic kidney disease: a report from the Chronic Kidney Disease in Children Study. Pediatr Nephrol. 2014;29(10):1987–95. https://doi.org/10.1007/s00467-014-2812-9
-
van Huis M, Bonthuis M, Sahpazova E, Mencarelli F, Spasojević B, Reusz G, et al. Considerable variations in growth hormone policy and prescription in paediatric end-stage renal disease across European countries-a report from the ESPN/ERA-EDTA registry. Nephrol Dial Transplant. 2016;31(4):609–19. https://doi.org/10.1093/ndt/gfv105
-
Liang Y, Shen Y, Jiang Y. The burden of protein-energy wasting in children with CKD3-5D: an observational study. Front Pediatr. 2026;14:1671377. https://doi.org/10.3389/fped.2026.1671377
-
Harambat J, Bonthuis M, van Stralen KJ, Ariceta G, Battelino N, Bjerre A, et al. Adult height in patients with advanced CKD requiring renal replacement therapy during childhood. Clin J Am Soc Nephrol. 2014;9(1):92–9. https://doi.org/10.2215/CJN.00890113
-
Настаушева Н.С., Стахурлова Л.И., Жданова О.А., и др. Физическое развитие детей с хронической болезнью почек (ХБП). Нефрология. 2015;19(3):32–38. [Nastausheva NS, Stakhurlova LI, Zhdanova OA, et al. Fizicheskoe razvitie detei s khronicheskoi bolezn’yu pochek (KhBP). Nefrologiya. 2015;19(3):32–38. (in Russ)]
-
Semash K, Akhmedov A, Dzhanbekov T, Umarov Q, Dustmurodov J. Implementation of a pediatric kidney transplantation program in Uzbekistan: Feasibility and early outcomes. World J Transplant. 2025;15(4):107728. https://doi.org/10.5500/wjt.v15.i4.107728
-
Zavyalova AN, Lebedev DA, Novikova VP, Smirnova NN, Firsova LA. Komponentnyi sostav tela detei s khronicheskoi bolezn’yu pochek po rezul’tatam bioimpedansometrii. Acta Biomedica Scientifica. 2023;8(2):184–194. https://doi.org/10.29413/ABS.2023-8.2.18. (in Russ)
-
Mahesh S, Kaskel F. Growth hormone axis in chronic kidney disease. Pediatr Nephrol. 2008;23(1):41–8. https://doi.org/10.1007/s00467-007-0527-x
-
Akchurin O, Molino AR, Schneider MF, Atkinson MA, Warady BA, Furth SL. Longitudinal Relationship Between Anemia and Statural Growth Impairment in Children and Adolescents With Nonglomerular CKD: Findings From the Chronic Kidney Disease in Children (CKiD) Study. Am J Kidney Dis. 2023;81(4):457–465.e1. https://doi.org/10.1053/j.ajkd.2022.09.019
-
Greenbaum LA, Muñoz A, Schneider MF, Kaskel FJ, Askenazi DJ, Jenkins R, et al. The association between abnormal birth history and growth in children with CKD. Clin J Am Soc Nephrol. 2011;6(1):14–21. https://doi.org/10.2215/CJN.08481109
-
Drube J, Wan M, Bonthuis M, Wühl E, Bacchetta J, Santos F, et al. Clinical practice recommendations for growth hormone treatment in children with chronic kidney disease. Nat Rev Nephrol. 2019;15(9):577–589. https://doi.org/10.1038/s41581-019-0161-4
-
Neuhaus TJ. Immunization in children with chronic renal failure: a practical approach. Pediatr Nephrol. 2004;19(12):1334–9. https://doi.org/10.1007/s00467-004-1597-7
-
Szczepańska M, Szprynger K, Mazur B, Szczepański T. Alphabeta and gammadelta T cell subsets in chronic renal failure in children on dialysis treatment. Pediatr Int. 2002;44(1):32–6. https://doi.org/10.104 6/j.1442-200x.2002.01501.x
-
Sánchez Hernández KV, Larrosa-Haro A, González Hita M, Martín Del Campo López F, Chávez Palencia C, Pérez Cortez G, et al. Interleukine 6 and C-reactive protein predict growth impairment and acute malnutrition in children and adolescents with chronic kidney disease. Nutr Hosp. 2019;36(6):1248–53. https://doi.org/10.20960/nh.02640
-
Chavers BM, Solid CA, Gilbertson DT, Collins AJ. Infection-related hospitalization rates in pediatric versus adult patients with end-stage renal disease in the United States. J Am Soc Nephrol. 2007;18(3):952–9. https://doi.org/10.1681/ASN.2006040406
-
Ng DK, Molino AR, Zhang S, Stonebrook EJ, Wong CS, Gyawali P, et al. The epidemiology of kidney and urinary tract infections in pediatric chronic kidney disease: prevalence, risk factors and association with GFR decline in the Chronic Kidney Disease in Children Study. Pediatr Nephrol. 2026;41(10):3377–87. https://doi.org/10.1007/s00467-026-07253-2
-
Watkins SL, Alexander SR, Brewer ED, Hesley TM, West DJ, Chan IS, et al. Response to recombinant hepatitis B vaccine in children and adolescents with chronic renal failure. Am J Kidney Dis. 2002;40(2):365–72. https://doi.org/10.1053/ajkd.2002.34521
-
Mericq V, Salas P, Pinto V, Cano F, Reyes L, Brown K, et al. Steroid withdrawal in pediatric kidney transplant allows better growth, lipids and body composition: a randomized controlled trial. Horm Res Paediatr. 2013;79(2):88–96. https://doi.org/10.1159/000347024
-
Hogan J, Schneider MF, Pai R, Denburg MR, Kogon A, Brooks ER, et al. Grip strength in children with chronic kidney disease. Pediatr Nephrol. 2020;35(5):891–899. https://doi.org/10.1007/s00467-019-04461-x
-
WHO Multicentre Growth Reference Study Group. WHO Child Growth Standards based on length/height, weight and age. Acta Paediatr Suppl. 2006;450:76–85. https://doi.org/10.1111/j.1651-2227.2006.tb02378.x
-
de Onis M, Onyango AW, Borghi E, Siyam A, Nishida C, Siekmann J. Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Organ. 2007;85(9):660–7. https://doi.org/10.2471/blt.07.043497
-
KDOQI Work Group. KDOQI Clinical Practice Guideline for Nutrition in Children with CKD: 2008 update. Executive summary. Am J Kidney Dis. 2009;53(3 Suppl 2):S11–104. https://doi.org/10.1053/j.ajkd. 2008.11.017
-
Karri MS, Dawman L, Sadasivam D, Vallabhaneni P, Mahajan S, Singh T, et al. Bioelectrical impedance analysis versus dual-energy X-ray absorptiometry for body composition assessment in children with chronic kidney disease. Eur J Pediatr. 2026;185(9):679. https://doi.org/10.1007/s00431-026-07355-x
-
Hodson EM, Willis NS, Craig JC. Growth hormone for children with chronic kidney disease. Cochrane Database Syst Rev. 2012;2012(2):CD003264. https://doi.org/10.1002/14651858.CD003264.pub3
-
Al-Uzri A, Matheson M, Gipson DS, Mendley SR, Hooper SR, Yadin O, et al. The impact of short stature on health-related quality of life in children with chronic kidney disease. J Pediatr. 2013;163(3):736–41.e1. https://doi.org/10.1016/j.jpeds.2013.03.016
Об авторах
Лицензия

Это произведение доступно по лицензии Creative Commons «Attribution» («Атрибуция») 4.0 Всемирная.